Replimune Group, Inc. (REPL)
8.54
+0.13
(+1.55%)
USD |
NASDAQ |
Apr 06, 16:00
8.54
0.00 (0.00%)
After-Hours: 17:16
Replimune Group SG&A Expense (TTM) : 103.07M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 317.74M |
| Phathom Pharmaceuticals, Inc. | 279.72M |
| REGENXBIO, Inc. | 82.86M |
| Corcept Therapeutics, Inc. | 448.72M |
| Catalyst Pharmaceuticals, Inc. | 171.18M |